(NYSE: CHE) Chemed's forecast annual revenue growth rate of 3.37% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.61%.
Chemed's revenue in 2025 is $2,511,915,000.On average, 2 Wall Street analysts forecast CHE's revenue for 2025 to be $37,184,634,169, with the lowest CHE revenue forecast at $37,168,605,304, and the highest CHE revenue forecast at $37,200,663,033. On average, 2 Wall Street analysts forecast CHE's revenue for 2026 to be $39,084,928,914, with the lowest CHE revenue forecast at $38,895,496,879, and the highest CHE revenue forecast at $39,274,360,949.
In 2027, CHE is forecast to generate $41,082,708,298 in revenue, with the lowest revenue forecast at $41,082,708,298 and the highest revenue forecast at $41,082,708,298.